Soluble fms-like tyrosine kinase-1 and atherosclerosis in chronic kidney disease

Tools

Item Type:	Editorial
Title:	Soluble fms-like tyrosine kinase-1 and atherosclerosis in chronic kidney disease
Creators Name:	Luft, F.C.
Abstract:	Vascular endothelial growth factor (VEGF) and its cousins, such as placental growth factor, have moved into the daily clinical arena. One-step-removed regulators, such as the VEGF splice variant soluble fms-like tyrosine kinase-1 (sFlt-1), now clinically emerge. sFlt-1 keeps our corneas 'clean.' However, sFlt-1 could also cause disease, such as preeclampsia. The report by Matsui et al. on ApoE and sFlt-1 gene-deleted mice could foster important subsequent research. We are limited only by our imaginations.
Keywords:	Atherosclerosis, Chronic Renal Insufficiency, Vascular Endothelial Growth Factor Receptor-1, Animals
Source:	Kidney International
ISSN:	0085-2538
Publisher:	Nature Publishing Group
Volume:	85
Number:	2
Page Range:	238-240
Date:	February 2014
Official Publication:	https://doi.org/10.1038/ki.2013.402
PubMed:	View item in PubMed

Repository Staff Only: item control page